Hodgkin Lymphoma on brentuximab vedotin.

      A retrospective study to determine response of pediatrics with relapsed or refractory Hodgkin Lymphoma on brentuximab vedotin. In addition, evaluate the cost effectiveness of using brentuximab in pediatric in the children cancer center.